ARATANA THERAPEUTICS, INC.·4

Jan 26, 5:34 PM ET

Standridge Brent 4

4 · ARATANA THERAPEUTICS, INC. · Filed Jan 26, 2018

Insider Transaction Report

Form 4
Period: 2018-01-25
Standridge Brent
Chief Operating Officer
Transactions
  • Award

    Common Stock

    2018-01-25+39,700109,967 total
  • Award

    Stock Option (Right to Buy)

    2018-01-25+60,00060,000 total
    Exercise: $4.83Exp: 2028-01-24Common Stock (60,000 underlying)
Footnotes (1)
  • [F1]Vests as to 25% of the total number of shares (rounded down to the nearest whole share) on January 29, 2019 and as to an additional 1/48th of the total number of shares (rounded down to the nearest whole share) on the same day of each of the 36 successive calendar months thereafter, such that the stock option shall be vested as to all shares on January 29, 2022, subject to continued service with the Issuer through the applicable vesting dates.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION